Vimarsana
Biggest News Aggregation in the World

Page 41 - Former Address News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Former Address. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Former Address Today - Breaking & Trending Today

LivaNova : Regulation FD Disclosure - Form 8-K - Vimarsana News

LivaNova : Regulation FD Disclosure - Form 8-K

Published: March 24, 2023

Livn-20230322 UNITED STATES SECURITIES AND... | March 24, 2023

Source: marketscreener.com
Related Topics:
City OfUnited KingdomUnited StatesEast SussexMichael HutchinsonSecurities ExchangeStatistical Analysis CommitteeSecurities Exchange ActExact NamePrincipal Executive OfficesTelephone NumberIncluding Area CodeFormer NameFormer AddressChanged Since Last ReportGeneral InstructionsSecurities ActExchange ActCurrent ReportPage Interactive Data FileSenior Vice PresidentChief LegalLivanova Plc Stock ExchangePress ReleaseEcurities Livn Gb00bymt0j19
NightHawk Biosciences : Non-Reliance on Previously Issued Financial Report - Form 8-K - Vimarsana News

NightHawk Biosciences : Non-Reliance on Previously Issued Financial Report - Form 8-K

Published: March 23, 2023

​ ​ UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ... | March 23, 2023

Source: marketscreener.com
Related Topics:
United StatesNorth CarolinaJeffrey WolfSecurities ExchangeCompany Annual Report On FormCommission File NumberHeat Biologics IncElusys Therapeutics IncCompany Quarterly Report On FormCompany Quarterly Reports On FormNighthawk Biosciences IncSecurities Exchange ActHawk BiosciencesFormer NameFormer AddressSecurities ActExchange ActPreviously Issued Financial StatementsRelated Audit ReportCompleted InterimAudit CommitteeNighthawk BiosciencesQuarterly ReportQuarterly ReportsSpecified Financial Statements
Cimpress : Costs Associated with Exit/Disposal - Form 8-K - Vimarsana News

Cimpress : Costs Associated with Exit/Disposal - Form 8-K

Published: March 23, 2023

Cmpr-20230320 UNITED STATES SECURITIES AND... | March 23, 2023

Source: marketscreener.com
Related Topics:
United StatesSeane QuinnXerox Technology ParkSecurities ExchangeName Of Exchange On WhichCommission File NumberSecurities Exchange ActExact NameIts CharterPrincipal Executive OfficesFormer NameFormer AddressChanged Since Last ReportGeneral InstructionSecurities ActExchange ActPrivate Securities Litigation Reform ActVice PresidentChief FinancialCimpress Plc Stock ExchangePress ReleaseEcurities Cmpr Ie00bkyc3f77
AAON : Certificate of Incorporation/Bylaws - Form 8-K - Vimarsana News

AAON : Certificate of Incorporation/Bylaws - Form 8-K

Published: March 15, 2023

Aaon-20230309 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM... | March 15, 2023

Source: marketscreener.com
Related Topics:
United StatesLukea BomerExchange CommissionAaon IncSecurities ExchangeCommission File NumberExchange ActYukon AvePrincipal Executive OfficesZip CodeFormer NameFormer AddressChanged Since Last ReportSecurities ActSecurities Exchange ActRestated BylawsVice ChairpersonPage Interactive Data FileNc Stock ExchangePress ReleaseXchange Aaon Us0003602069
Sangamo Therapeutics : Open Market Sale Agreement - Form 8-K - Vimarsana News

Sangamo Therapeutics : Open Market Sale Agreement - Form 8-K

Published: March 7, 2023

Sgmo-20230307 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ... | March 7, 2023

Source: marketscreener.com
Related Topics:
United StatesScottb WilloughbyExchange Commission OnCompany Registration Statementon FormK CooleyConsent Of CooleySangamo Therapeutics IncOpinion Of CooleySecurities ExchangeSecurities Exchange ActZip CodeFormer NameFormer AddressChanged Since Last ReportSecurities ActExchange ActSangamo TherapeuticsOpen Market Sale AgreementOriginal Sales AgreementSales AgreementCommon StockRemaining SharesRegistration Statementon FormExchange CommissionRemaining Sharespursuant